A detailed history of Hemington Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Hemington Wealth Management holds 2,595 shares of AMGN stock, worth $726,625. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,595
Previous 2,533 2.45%
Holding current value
$726,625
Previous $791,000 4.93%
% of portfolio
0.22%
Previous 0.27%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $19,181 - $20,917
62 Added 2.45%
2,595 $830,000
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $1,313 - $1,596
5 Added 0.2%
2,533 $791,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $140,350 - $169,420
-522 Reduced 17.11%
2,528 $719,000
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $126,827 - $143,076
496 Added 19.42%
3,050 $878,000
Q3 2023

Oct 20, 2023

SELL
$218.65 - $271.46 $15,742 - $19,545
-72 Reduced 2.74%
2,554 $686,000
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $7,499 - $8,867
-35 Reduced 1.32%
2,626 $583,000
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $903 - $1,100
-4 Reduced 0.15%
2,661 $643,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $3,206 - $4,074
14 Added 0.53%
2,665 $699,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $4,152 - $4,621
18 Added 0.68%
2,651 $645,000
Q1 2022

May 04, 2022

BUY
$219.27 - $242.57 $284,393 - $314,613
1,297 Added 97.08%
2,633 $637,000
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $232,689 - $266,292
-1,170 Reduced 46.69%
1,336 $307,000
Q3 2021

Oct 06, 2021

SELL
$212.27 - $248.7 $528,552 - $619,263
-2,490 Reduced 49.84%
2,506 $533,000
Q2 2021

Jul 09, 2021

SELL
$233.58 - $259.14 $4,671 - $5,182
-20 Reduced 0.4%
4,996 $1.22 Million
Q1 2021

Apr 12, 2021

BUY
$221.91 - $258.6 $816,628 - $951,648
3,680 Added 275.45%
5,016 $1.25 Million
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $289,083 - $344,247
1,336 New
1,336 $307,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.